Iwata, H., Masuda, N., Kim, S., Inoue, K., Rai, Y., Fujita, T., . . . Chan, A. (2019). Neratinib after trastuzumab-based adjuvant therapy in patients from Asia with early stage HER2-positive breast cancer. Future Medicine.
Chicago Style (17th ed.) CitationIwata, Hiroji, et al. Neratinib After Trastuzumab-based Adjuvant Therapy in Patients from Asia with Early Stage HER2-positive Breast Cancer. Future Medicine, 2019.
MLA (9th ed.) CitationIwata, Hiroji, et al. Neratinib After Trastuzumab-based Adjuvant Therapy in Patients from Asia with Early Stage HER2-positive Breast Cancer. Future Medicine, 2019.
Warning: These citations may not always be 100% accurate.